Disease Management

"Disease Management" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A broad approach to appropriate coordination of the entire disease treatment process that often involves shifting away from more expensive inpatient and acute care to areas such as preventive medicine, patient counseling and education, and outpatient care. This concept includes implications of appropriate versus inappropriate therapy on the overall cost and clinical outcome of a particular disease. (From Hosp Pharm 1995 Jul;30(7):596)

Descriptor ID	D019468
MeSH Number(s)	N04.590.607
Concept/Terms	Disease Management Disease Management Disease Managements Management, Disease Managements, Disease

Below are MeSH descriptors whose meaning is more general than "Disease Management".

Below are MeSH descriptors whose meaning is related to "Disease Management".

Below are MeSH descriptors whose meaning is more specific than "Disease Management".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Disease Management" by people in this website by year, and whether "Disease Management" was a major or minor topic of these publications.

Bar chart showing 145 publications over 22 distinct years, with a maximum of 17 publications in 2016

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1997	1	0	1
1998	1	0	1
1999	0	2	2
2001	2	1	3
2002	0	3	3
2003	3	0	3
2004	1	3	4
2006	1	2	3
2007	2	3	5
2008	3	1	4
2009	0	3	3
2011	0	7	7
2012	1	5	6
2013	3	3	6
2014	5	5	10
2015	4	7	11
2016	10	7	17
2017	7	7	14
2018	3	8	11
2019	4	9	13
2020	5	8	13
2021	0	5	5

Below are the most recent publications written about "Disease Management" by people in Profiles.

Bonner A, Resnick B. Changing the dynamic: What can we learn from infectious disease management in long-term care settings? Geriatr Nurs. 2022 Jan-Feb; 43:A1-A2.

View in: PubMed
Chapin J, Cohen AR, Neufeld EJ, Vichinsky E, Giardina PJ, Boudreaux J, Le BC, Kenney K, Trimble S, Thompson AA. An update on the US adult thalassaemia population: a report from the CDC thalassaemia treatment centres. Br J Haematol. 2022 01; 196(2):380-389.

View in: PubMed
Rosiñol L, Beksac M, Zamagni E, Van de Donk NWCJ, Anderson KC, Badros A, Caers J, Cavo M, Dimopoulos MA, Dispenzieri A, Einsele H, Engelhardt M, Fernández de Larrea C, Gahrton G, Gay F, Hájek R, Hungria V, Jurczyszyn A, Kröger N, Kyle RA, Leal da Costa F, Leleu X, Lentzsch S, Mateos MV, Merlini G, Mohty M, Moreau P, Rasche L, Reece D, Sezer O, Sonneveld P, Usmani SZ, Vanderkerken K, Vesole DH, Waage A, Zweegman S, Richardson PG, Bladé J. Expert review on soft-tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations. Br J Haematol. 2021 08; 194(3):496-507.

View in: PubMed
Terpos E, Mikhael J, Hajek R, Chari A, Zweegman S, Lee HC, Mateos MV, Larocca A, Ramasamy K, Kaiser M, Cook G, Weisel KC, Costello CL, Elliott J, Palumbo A, Usmani SZ. Management of patients with multiple myeloma beyond the clinical-trial setting: understanding the balance between efficacy, safety and tolerability, and quality of life. Blood Cancer J. 2021 02 18; 11(2):40.

View in: PubMed
Rosellini M, Santoni M, Mollica V, Rizzo A, Cimadamore A, Scarpelli M, Storti N, Battelli N, Montironi R, Massari F. Treating Prostate Cancer by Antibody-Drug Conjugates. Int J Mol Sci. 2021 Feb 04; 22(4).

View in: PubMed
Mikuls TR, Johnson SR, Fraenkel L, Arasaratnam RJ, Baden LR, Bermas BL, Chatham W, Cohen S, Costenbader K, Gravallese EM, Kalil AC, Weinblatt ME, Winthrop K, Mudano AS, Turner A, Saag KG. American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID-19 Pandemic: Version 3. Arthritis Rheumatol. 2021 02; 73(2):e1-e12.

View in: PubMed
Patel JN, Robinson M, Jagosky M, Slaughter D, Arnall J, Jandrisevits E, Matusz-Fisher A, Atrash S, Paul B, Bhutani M, Voorhees P, Usmani SZ. Thromboembolism Incidence and Risk Factors in Multiple Myeloma After First Exposure to Immunomodulatory Drug-Based Regimens. Clin Lymphoma Myeloma Leuk. 2021 03; 21(3):188-198.e2.

View in: PubMed
Torres Canizales J, Ferreras C, Pascual A, Alonso L, Regueiro A, Plaza M, Pérez Hurtado JM, Benito A, Couselo JM, Fuster JL, Díaz-Almirón M, Bueno D, Mozo Y, Gómez López A, Vicario JL, Balas A, Sisinni L, Díaz de Heredia C, Pérez-Martínez A. Haploidentical transplantation in pediatric non-malignant diseases: A retrospective analysis on behalf of the Spanish Group for Hematopoietic Transplantation (GETH). Eur J Haematol. 2021 Feb; 106(2):196-204.

View in: PubMed
Sahu KK, Cerny J. A review on how to do hematology consults during COVID-19 pandemic. Blood Rev. 2021 05; 47:100777.

View in: PubMed
Abraham GM, Obley AJ, Humphrey LL, Qaseem A, Centor RM, Akl E, Forceia MA, Haeme R, Hamilton PG, Hood GA, Jokela JA, Kansagara DL, Levine MA, Mason JR, Marcucci M. World Health Organization Guidelines on Treatment of Hepatitis C Virus Infection: Best Practice Advice From the American College of Physicians. Ann Intern Med. 2021 01; 174(1):98-100.

View in: PubMed

People

Explore

Similar Concepts

Top Journals